MMedication Read More ‘Blockbuster’ reatrutide is coming. Will it help Louisiana? | Louisiana HealthSeptember 4, 2026 A new obesity medication is coming, one that may prove a “blockbuster” in states like Louisiana that struggle with…
MMedication Read More How GLP-1-Taking Dietitians Are Changing the Medication’s StigmaSeptember 4, 2026 10 min read Something strange started happening to Gianna Beasley four years ago. Despite doing everything right with…
MMedication Read More Bridge to Fit: Before you start GLP-1 medications, read thisSeptember 4, 2026 Now, I’m not a doctor, so I’m not recommending or not recommending weight loss drugs, period. That’s a…
MMedication Read More Epinephrine injections recalled over sterility concernsSeptember 4, 2026 FDA announces nationwide recall of epinephrine injections over sterility and particulate concerns A nationwide voluntary recall of three…
MMedication Read More FDA tracking hundreds of reports tied to compounded weight-loss drugs, unapproved peptidesSeptember 4, 2026 (WBAY) – The FDA is tracking hundreds of reported problems involving compounded weight-loss medications, as unapproved peptide products…
MMedication Read More Hack of the day: How to find your nearest Jan Aushadhi storeSeptember 4, 2026 Affordable healthcare is a pressing concern for millions of patients across India. Government-supported Jan Aushadhi stores provide generic…
MMedication Read More NZ’s new medicines fast-track promises quicker approvals. But what about access?September 4, 2026 A surge in severe respiratory illness has been placing New Zealand’s hospitals under intense pressure over recent weeks.…
MMedication Read More The Third Global Summit on Traditional Medicine set for November 2027September 4, 2026 © WHO Dr Rajesh Kotecha, Secretary, Ministry of Ayush, Government of India (centre); Dr Pongsadhorn Pokpermdee, Director General, Department…
MMedication Read More GLP-1 Scripts Rising Faster Among Adults With Serious Mental IllnessSeptember 4, 2026 People with serious mental illness (SMI) face high cardiovascular risk, making GLP-1 drugs a potential tool to reduce…
MMedication Read More Mounjaro: FDA Approves GLP-1 for Cardiovascular Risk ReductionSeptember 3, 2026 Share on PinterestThe FDA has approved Mounjaro for cardiovascular risk reduction in people with type 2 diabetes. Milko…
MMedication Read More Cupping Therapy ExplainedSeptember 3, 2026 ATLANTA, Ga. (ATL Live) – From star athletes to top beauty influencers, it seems like everyone is sporting…
MMedication Read More How Thai beauty brand Sudtana brought family herbal remedies to luxury hotels across AsiaSeptember 3, 2026 Small rituals keep her grounded – a few deep breaths during a hectic day, a reminder that not…